Rhumbline Advisers Orgenesis Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$4.19 - $5.88 $81,545 - $114,436
-19,462 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$4.77 - $8.08 $596 - $1,010
125 Added 0.65%
19,462 $112,000
Q4 2020

Feb 10, 2021
BUY
$4.4 - $5.63 $15,298 - $19,575
3,477 Added 21.92%
19,337 $87,000
Q3 2020

Nov 12, 2020
SELL
$4.75 - $5.99 $24,391 - $30,758
-5,135 Reduced 24.46%
15,860 $80,000
Q2 2020

Aug 13, 2020
BUY
$3.6 - $7.84 $75,582 - $164,600
20,995 New
20,995 $128,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email